Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 283

1.

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.

Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S.

Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.188. [Epub ahead of print]

PMID:
27427921
2.

Uniaxial ferroelectric quantum criticality in multiferroic hexaferrites BaFe12O19 and SrFe12O19.

Rowley SE, Chai YS, Shen SP, Sun Y, Jones AT, Watts BE, Scott JF.

Sci Rep. 2016 May 17;6:25724. doi: 10.1038/srep25724.

3.

Altered Glycolysis and Mitochondrial Respiration in a Zebrafish Model of Dravet Syndrome.

Kumar MG, Rowley S, Fulton R, Dinday MT, Baraban SC, Patel M.

eNeuro. 2016 Apr 5;3(2). pii: ENEURO.0008-16.2016. doi: 10.1523/ENEURO.0008-16.2016. eCollection 2016 Mar-Apr.

4.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, Pertesi M, Voegele C, Mebirouk N, Robinot N, Durand G, Forey N, Luben RN, Ahmed S, Aittomäki K, Anton-Culver H, Arndt V; Australian Ovarian Cancer Study Group, Baynes C, Beckman MW, Benitez J, Van Den Berg D, Blot WJ, Bogdanova NV, Bojesen SE, Brenner H, Chang-Claude J, Chia KS, Choi JY, Conroy DM, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Eriksson M, Fasching PA, Figueroa J, Flyger H, Fostira F, García-Closas M, Giles GG, Glendon G, González-Neira A, Guénel P, Haiman CA, Hall P, Hart SN, Hartman M, Hooning MJ, Hsiung CN, Ito H, Jakubowska A, James PA, John EM, Johnson N, Jones M, Kabisch M, Kang D; kConFab Investigators, Kosma VM, Kristensen V, Lambrechts D, Li N; Lifepool Investigators, Lindblom A, Long J, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Meindl A, Mitchell G, Muir K; NBCS Investigators, Nevelsteen I, van den Ouweland A, Peterlongo P, Phuah SY, Pylkäs K, Rowley SM, Sangrajrang S, Schmutzler RK, Shen CY, Shu XO, Southey MC, Surowy H, Swerdlow A, Teo SH, Tollenaar RA, Tomlinson I, Torres D, Truong T, Vachon C, Verhoef S, Wong-Brown M, Zheng W, Zheng Y, Nevanlinna H, Scott RJ, Andrulis IL, Wu AH, Hopper JL, Couch FJ, Winqvist R, Burwinkel B, Sawyer EJ, Schmidt MK, Rudolph A, Dörk T, Brauch H, Hamann U, Neuhausen SL, Milne RL, Fletcher O, Pharoah PD, Campbell IG, Dunning AM, Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trench G.

J Med Genet. 2016 May;53(5):298-309. doi: 10.1136/jmedgenet-2015-103529. Epub 2016 Feb 26.

PMID:
26921362
5.

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.

Thompson ER, Rowley SM, Li N, McInerny S, Devereux L, Wong-Brown MW, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG.

J Clin Oncol. 2016 May 1;34(13):1455-9. doi: 10.1200/JCO.2015.63.7454. Epub 2016 Jan 19.

PMID:
26786923
6.

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.

Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME, McCarty J, Nakamura R, Pulsipher MA, Rowley S, Leifer E, Carter SL, DiFronzo NL, Horowitz MM, Confer D, Deeg HJ, Eapen M.

Lancet Haematol. 2015 Sep;2(9):e367-75. doi: 10.1016/S2352-3026(15)00147-7. Epub 2015 Sep 2.

PMID:
26685770
7.

Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.

Hunter SM, Rowley SM, Clouston D; KCon Fab Investigators, Li J, Lupat R, Krishnananthan N, Risbridger G, Taylor R, Bolton D, Campbell IG, Thorne H.

Urol Oncol. 2016 Mar;34(3):120.e9-16. doi: 10.1016/j.urolonc.2015.10.009. Epub 2015 Nov 14.

PMID:
26585945
8.

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.

Hunter SM, Anglesio MS, Ryland GL, Sharma R, Chiew YE, Rowley SM, Doyle MA, Li J, Gilks CB, Moss P, Allan PE, Stephens AN, Huntsman DG, deFazio A, Bowtell DD; Australian Ovarian Cancer Study Group, Gorringe KL, Campbell IG.

Oncotarget. 2015 Nov 10;6(35):37663-77. doi: 10.18632/oncotarget.5438.

9.

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.

Thompson ER, Gorringe KL, Rowley SM, Li N, McInerny S, Wong-Brown MW, Devereux L, Li J; Lifepool Investigators, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG.

Sci Rep. 2015 Oct 12;5:14800. doi: 10.1038/srep14800.

10.

Impact of adolescent ethanol exposure and adult amphetamine self-administration on evoked striatal dopamine release in male rats.

Granholm L, Rowley S, Ellgren M, Segerström L, Nylander I.

Psychopharmacology (Berl). 2015 Dec;232(24):4421-31. doi: 10.1007/s00213-015-4070-3. Epub 2015 Sep 26.

11.

Quantum criticality in a uniaxial organic ferroelectric.

Rowley SE, Hadjimichael M, Ali MN, Durmaz YC, Lashley JC, Cava RJ, Scott JF.

J Phys Condens Matter. 2015 Oct 7;27(39):395901. doi: 10.1088/0953-8984/27/39/395901. Epub 2015 Sep 11.

PMID:
26360383
12.

Copy number analysis of ductal carcinoma in situ with and without recurrence.

Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, Mann GB, Campbell IG.

Mod Pathol. 2015 Sep;28(9):1174-84. doi: 10.1038/modpathol.2015.75. Epub 2015 Jun 19.

PMID:
26321097
13.
14.

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.

Thompson ER, Gorringe KL, Rowley SM, Wong-Brown MW, McInerny S, Li N, Trainer AH, Devereux L, Doyle MA, Li J, Lupat R, Delatycki MB; LifePool Investigators, Mitchell G, James PA, Scott RJ, Campbell IG.

Breast Cancer Res. 2015 Aug 19;17:111. doi: 10.1186/s13058-015-0627-7.

15.

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.

Ryland GL, Hunter SM, Doyle MA, Caramia F, Li J, Rowley SM, Christie M, Allan PE, Stephens AN, Bowtell DD; Australian Ovarian Cancer Study Group, Campbell IG, Gorringe KL.

Genome Med. 2015 Aug 7;7(1):87. doi: 10.1186/s13073-015-0210-y. eCollection 2015.

16.

Loss of heterozygosity: what is it good for?

Ryland GL, Doyle MA, Goode D, Boyle SE, Choong DY, Rowley SM, Li J; Australian Ovarian Cancer Study Group, Bowtell DD, Tothill RW, Campbell IG, Gorringe KL.

BMC Med Genomics. 2015 Aug 1;8:45. doi: 10.1186/s12920-015-0123-z.

17.

Reactive oxygen species mediate cognitive deficits in experimental temporal lobe epilepsy.

Pearson JN, Rowley S, Liang LP, White AM, Day BJ, Patel M.

Neurobiol Dis. 2015 Oct;82:289-97. doi: 10.1016/j.nbd.2015.07.005. Epub 2015 Jul 13.

PMID:
26184893
18.

Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach.

Sanstead E, Kenyon C, Rowley S, Enns E, Miller C, Ehresmann K, Kulasingam S.

Am J Public Health. 2015 Sep;105(9):e42-7. doi: 10.2105/AJPH.2015.302794. Epub 2015 Jul 16.

PMID:
26180973
19.

The Validity and Clinical Utility of the COVERS Scale and Pain Assessment Tool for Assessing Pain in Neonates Admitted to an Intensive Care Unit.

O'Sullivan AT, Rowley S, Ellis S, Faasse K, Petrie KJ.

Clin J Pain. 2016 Jan;32(1):51-7. doi: 10.1097/AJP.0000000000000228.

PMID:
25756556
20.

Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy.

Rowley S, Liang LP, Fulton R, Shimizu T, Day B, Patel M.

Neurobiol Dis. 2015 Mar;75:151-8. doi: 10.1016/j.nbd.2014.12.025. Epub 2015 Jan 17.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk